Austar Lifesciences 過去の業績
過去 基準チェック /06
Austar Lifesciencesの収益は年間平均-0.9%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間20.8% 13.1%割合で 増加しています。
主要情報
-0.9%
収益成長率
-0.9%
EPS成長率
| Life Sciences 業界の成長 | 41.4% |
| 収益成長率 | 13.1% |
| 株主資本利益率 | -2.9% |
| ネット・マージン | -1.3% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 32% But Its Business Prospects Need A Lift Too
Oct 16
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23収支内訳
収支内訳
Austar Lifesciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 1,545 | -19 | 268 | 51 |
| 31 Mar 24 | 1,654 | -26 | 301 | 53 |
| 31 Dec 23 | 1,764 | -33 | 333 | 55 |
| 30 Jun 23 | 1,972 | 51 | 329 | 64 |
| 31 Mar 23 | 2,065 | 78 | 316 | 67 |
| 31 Dec 22 | 2,157 | 104 | 303 | 70 |
| 30 Sep 22 | 2,246 | 96 | 307 | 71 |
| 30 Jun 22 | 2,264 | 105 | 304 | 72 |
| 31 Mar 22 | 2,139 | 191 | 304 | 69 |
| 31 Dec 21 | 2,015 | 277 | 304 | 66 |
| 30 Sep 21 | 1,824 | 258 | 304 | 59 |
| 30 Jun 21 | 1,633 | 238 | 304 | 52 |
| 31 Mar 21 | 1,465 | 136 | 281 | 50 |
| 31 Dec 20 | 1,296 | 33 | 259 | 48 |
| 30 Sep 20 | 1,193 | 25 | 253 | 47 |
| 30 Jun 20 | 1,089 | 17 | 246 | 45 |
| 31 Mar 20 | 1,069 | 12 | 248 | 44 |
| 31 Dec 19 | 1,049 | 8 | 251 | 43 |
| 30 Sep 19 | 1,007 | 8 | 234 | 39 |
| 30 Jun 19 | 966 | 8 | 216 | 36 |
| 31 Mar 19 | 891 | 4 | 200 | 33 |
| 31 Dec 18 | 817 | 0 | 183 | 30 |
| 30 Sep 18 | 724 | -16 | 182 | 29 |
| 30 Jun 18 | 631 | -33 | 182 | 28 |
| 31 Mar 18 | 589 | -43 | 177 | 27 |
| 31 Dec 17 | 547 | -54 | 171 | 26 |
| 30 Sep 17 | 587 | -43 | 160 | 27 |
| 30 Jun 17 | 628 | -32 | 149 | 28 |
| 31 Mar 17 | 650 | -25 | 150 | 30 |
| 31 Dec 16 | 673 | -19 | 151 | 32 |
| 30 Sep 16 | 648 | -17 | 146 | 32 |
| 30 Jun 16 | 624 | -16 | 141 | 31 |
| 31 Mar 16 | 626 | -5 | 134 | 29 |
| 31 Dec 15 | 628 | 6 | 127 | 27 |
| 30 Sep 15 | 640 | 24 | 122 | 26 |
| 30 Jun 15 | 652 | 43 | 118 | 26 |
| 31 Mar 15 | 666 | 54 | 120 | 25 |
| 31 Dec 14 | 680 | 65 | 122 | 24 |
| 30 Sep 14 | 676 | 58 | 128 | 24 |
| 30 Jun 14 | 672 | 51 | 133 | 24 |
| 31 Mar 14 | 689 | 52 | 126 | 24 |
| 31 Dec 13 | 705 | 54 | 120 | 24 |
質の高い収益: 6118は現在利益が出ていません。
利益率の向上: 6118は現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 6118は利益が出ておらず、過去 5 年間で損失は年間0.9%の割合で増加しています。
成長の加速: 6118の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: 6118は利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -3.9% ) と比較することは困難です。
株主資本利益率
高いROE: 6118は現在利益が出ていないため、自己資本利益率 ( -2.85% ) はマイナスです。